Canada Approves GW's Cannabis Drug for Multiple Sclerosis Sufferers

"Canada Approves GW's Cannabis Drug for Multiple Sclerosis Sufferers GW Pharmaceuticals has become the first drug company to gain approval to launch a cannabis-based medicine for multiple sclerosis sufferers. The approval in Canada comes after six years of work for the...

Big Pharma pushes for patents of pot-based pills

I found this statistic surprising: in 1994 there were only two pot-based pharmaceutical drugs in development in the US, while in 2004 there were 27. That's a big leap, one that could potentially hold some clout in...

closeSign in to NowPublic

is reporting from